Aytu Biopharma (AYTU) Free Cash Flow (QoQ) (2011 - 2026)
Aytu Biopharma (AYTU) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 22.97 Mn | -3.75 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -214.32% |
| Dec 31, 2025 | 691.91% |
| Sep 30, 2025 | -122.18% |
| Jun 30, 2025 | 142.70% |
| Mar 31, 2025 | -325.04% |
| Dec 31, 2024 | 318.63% |
| Sep 30, 2024 | -18.71% |
| Jun 30, 2024 | -339.76% |
| Mar 31, 2024 | -88.15% |
| Dec 31, 2023 | 36.02% |
| Sep 30, 2023 | -102.25% |
| Jun 30, 2023 | 421.81% |
| Mar 31, 2023 | -17.04% |
| Dec 31, 2022 | 72.66% |
| Sep 30, 2022 | -28.26% |
| Jun 30, 2022 | 22.16% |
| Mar 31, 2022 | -3.43% |
| Dec 31, 2021 | -131.92% |
| Sep 30, 2021 | -156.23% |
| Dec 31, 2020 | 63.66% |